Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 227,741,297 papers from all fields of science
Search
Sign In
Create Free Account
National Institute of Drug Abuse
Known as:
NIDA (US)
, National Institute on Drug Abuse (U.S.)
, NIDA
Expand
An institute within the National Institutes of Health with the mission to lead the nation in bringing the power of science to bear on drug abuse and…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
2 relations
legislation & jurisprudence
standards characteristics
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Review
2009
Review
2009
Cannabinoid CB1 receptor antagonists as potential pharmacotherapies for drug abuse disorders
P. Beardsley
,
B. Thomas
,
L. McMahon
International Review of Psychiatry
2009
Corpus ID: 205645496
Since the discovery of the cannabinoid CB1 receptor (CB1R) in 1988, and subsequently of the CB2 receptor (CB2R) in 1993, there…
Expand
Highly Cited
2006
Highly Cited
2006
Recreational Viagra Use and Sexual Risk among Drug Abusing Men.
D. Fisher
,
R. Malow
,
R. Rosenberg
,
G. Reynolds
,
N. Farrell
,
A. Jaffe
American Journal of Infectious Diseases
2006
Corpus ID: 17718196
Until recently, the Viagra connection to HIV was anchored in older adults. However, CDC investigation showed stability in 50+ HIV…
Expand
Highly Cited
2006
Highly Cited
2006
Technology-Based Training in Cognitive Behavioral Therapy for Substance Abuse Counselors
K. Weingardt
,
Steven W. Villafranca
,
C. Levin
Substance Abuse
2006
Corpus ID: 37500342
This study compared the learning outcomes achieved by 166 practicing substance abuse counselors who were randomized to one of…
Expand
2006
2006
A combined ligand-based and target-based drug design approach for G-protein coupled receptors: application to salvinorin A, a selective kappa opioid receptor agonist
Nidhi Singh
,
G. Chevé
,
D. Ferguson
,
C. McCurdy
J. Comput. Aided Mol. Des.
2006
Corpus ID: 13774089
Combined ligand-based and target-based drug design approaches provide a synergistic advantage over either method individually…
Expand
Highly Cited
2005
Highly Cited
2005
Neurochemical effects of cocaine in adolescence compared to adulthood.
Kirstie H. Stansfield
,
C. Kirstein
Brain research. Developmental brain research
2005
Corpus ID: 12787010
Review
2002
Review
2002
Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence.
R. Mattick
,
J. Kimber
,
C. Breen
,
M. Davoli
Cochrane Database of Systematic Reviews
2002
Corpus ID: 263488164
BACKGROUND Buprenorphine has recently been reported to be an alternative to methadone and LAAM for maintenance treatment of…
Expand
Highly Cited
2000
Highly Cited
2000
Self-help group attendance and participation among cocaine dependent patients.
Roger D. Weiss
,
Roger D. Weiss
,
+8 authors
Jacques P. Barber
Drug and Alcohol Dependence
2000
Corpus ID: 31196635
1995
1995
Changes in CNS neuropeptide FF-like material, pain sensitivity, and opiate dependence following chronic morphine treatment
L. Stinus
,
M. Allard
,
L. Gold
,
G. Simonnet
Peptides
1995
Corpus ID: 25132684
Highly Cited
1994
Highly Cited
1994
Drug treatment on demand--not.
L. Wenger
,
M. Rosenbaum
Journal of Psychoactive Drugs
1994
Corpus ID: 46123003
Drug treatment on demand, appropriate and affordable drug treatment for injection drug users who are "ready" to enter a program…
Expand
Highly Cited
1986
Highly Cited
1986
Prediction to Successful Treatment Outcome by Client Characteristics and Retention in Treatment in Adolescent Drug Treatment Programs: A Large-Scale Cross Validation Study
A. S. Friedman
,
N. Glickman
,
M. Morrissey
Journal of Drug Education
1986
Corpus ID: 27433645
NIDA–CODAP file data on adolescent clients admitted to thirty selected outpatient programs were available for calendar years 1979…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE